The VIRLIX brand, founded in 1966 (Belgium), from 359 sister brands and 2214 competing brands. VIRLIX is owned by UCB, listed on the stock exchange of Bruxelles Its International Securities Identification Number (ISIN) is BE0003739530. VIRLIX belongs to the Biotechnology business sector.

VIRLIX is a brand of UCB (UCB) Share price

International deposit : 1966 Business sector Biotechnology

Share price and profitability of the share UCB (VIRLIX)

Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 120.00

Portfolio valuation
UCB (VIRLIX) over 5 years* EUR 203.59

Stock market history UCB (VIRLIX)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
UCB

Zogenix
Zogenix
Handl Therapeutics
Handl Therapeutics
Engage Therapeutics
Engage Therapeutics
Ra Pharmaceuticals
Ra Pharmaceuticals
UCB
UCB
See more brands of UCB

Rival brands
VIRLIX

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS